No Data
TD Cowen Keeps Their Buy Rating on Boston Scientific (BSX)
Optimistic Buy Rating for Boston Scientific Driven by Promising WATCHMAN FLX Trial Results
Boston Scientific Reports Outcomes From Trial of LAAC Device
Express News | Boston Scientific Watchman Flx™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the Option Clinical Trial
Boston Scientific WATCHMAN FLX Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
News On Axonics Inc. (AXNX) Now Under BSX
